NEUROLOGIX SIGNS PACT WITH DIAMYD SUBSIDIARY ON PARKINSON'S THERAPY

Neurologix, Inc., a biotech company committed to developing innovative gene therapies for the brain and central nervous systems, has entered into a licensing agreement with a subsidiary of Diamyd Medical, a biotechnology company based in Stockholm, Sweden, and Pittsburgh, PA.
Pharmabiz